February 22, 2022
The innovative micro-invasive EchoLaser system will allow the facilities of the Korian group to provide an even excellent service to their patients suffering from prostate and thyroid pathologies.
The scope is to reduce the time of the operation as well as the costs of hospitalization.
Click here to get more information.
January 14, 2022
Consequent to the rapid increase of the hospitals where EchoLaser SoracteLite is used to treat BPH, Elesta has initiated a national project for the elaboration of a Delphi Consensus (which will be submitted for publication), aiming at standardizing the way this innovative treatment modality is performed. The project will be managed by a group of urologists of the Careggi hospital in Florence and by a scientific board whose members are the principal investigators of the Italian prospective studies (some of which have been already published and others are still enrolling patients).
November 1, 2021
Effective from July 1, 2022, the specific CPT code will allow EchoLaser SoracteLite treatment to spread quickly, with benefits for hospitals, payers and most of all patients.
Click here to get more details.